Compare Medpace Holdings Inc (MEDP) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.54. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | VCIT | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Fixed Income |
52-Week High | $620.59 | $84.82 |
52-Week Low | $308.88 | $81.45 |
Enterprise Value | $14.55B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
